Table 2 Patient status upon admission and in-hospital management
From: Serum zinc concentration in patients with myocardial infarction: a retrospective study
Overall cohort (n = 243) | Low zinc group (n = 111) | High zinc group (n = 132) | P | |
|---|---|---|---|---|
Time from the onset to hospital (hours) | 2.3 [1.1, 6.2] | 2.9 [1.3, 6.5] | 2.0 [1.0, 6.1] | 0.46 |
STEMI | 162/243 (59%) | 74/111 (64%) | 9/7132 (69%) | 0.41 |
Killip class (I/II/III/IV) | 199/18/11/15 | 85/12/8/6 | 114/6/3/9 | 0.062 |
Killip class ≥ 2 | 44/243 (18%) | 26/111 (23%) | 18/132 (14%) | 0.048 |
LVEF (%) | 56 ± 10 | 54 ± 10 | 57 ± 10 | 0.014 |
Emergent CAG | 231/243 (95%) | 104/111 (94%) | 127/132 (96%) | 0.37 |
Primary PCI | 211/243 (87%) | 96/111 (86%) | 115/132 (87%) | 0.88 |
IABP | 17/243 (7%) | 10/111 (9%) | 7/132 (5%) | 0.26 |
PCPS | 1/243 (0.4%) | 1/111 (1%) | 0/132 (0%) | 0.27 |
Peak CK (U/L) | 1246 [437, 2992] | 1198 [389, 2914] | 1504 [496, 3095] | 0.84 |
Medication | ||||
ACEI/ARB | 203/243 (84%) | 87/111 (78%) | 116/132 (88%) | 0.047 |
β-blocker | 175/243 (72%) | 88/111 (79%) | 87/132 (66%) | 0.021 |
MRA | 12/243 (5%) | 4/111 (4%) | 8/132 (6%) | 0.38 |
Statin | 213/243 (88%) | 95/111 (86%) | 118/132 (89%) | 0.37 |